These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23936312)

  • 1. WT1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regulating cyclin D1 and p-pRb in vitro and in vivo.
    Xu C; Wu C; Xia Y; Zhong Z; Liu X; Xu J; Cui F; Chen B; Røe OD; Li A; Chen Y
    PLoS One; 2013; 8(8):e68837. PubMed ID: 23936312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WT1 promotes invasion of NSCLC via suppression of CDH1.
    Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
    J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilms' tumor 1 enhances Cisplatin-resistance of advanced NSCLC.
    Wu C; Wang Y; Xia Y; He S; Wang Z; Chen Y; Wu C; Shu Y; Jiang J
    FEBS Lett; 2014 Dec; 588(24):4566-72. PubMed ID: 25447528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA WT1-AS over-expression inhibits non-small cell lung cancer cell stemness by down-regulating TGF-β1.
    Jiang X; Wang J; Fang L
    BMC Pulm Med; 2020 Apr; 20(1):113. PubMed ID: 32349718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of PAX6 by shRNA inhibits proliferation and cell cycle progression of human non-small cell lung cancer cell lines.
    Zhao X; Yue W; Zhang L; Ma L; Jia W; Qian Z; Zhang C; Wang Y
    PLoS One; 2014; 9(1):e85738. PubMed ID: 24454925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer.
    Cao W; Ribeiro Rde O; Liu D; Saintigny P; Xia R; Xue Y; Lin R; Mao L; Ren H
    PLoS One; 2012; 7(12):e52984. PubMed ID: 23300840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.
    Vonlanthen S; Heighway J; Kappeler A; Altermatt HJ; Borner MM; Betticher DC
    Int J Oncol; 2000 May; 16(5):951-7. PubMed ID: 10762631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
    Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
    Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathway.
    Tian XP; Jin XH; Li M; Huang WJ; Xie D; Zhang JX
    Mol Cancer; 2017 Apr; 16(1):74. PubMed ID: 28372542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).
    Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
    J Cancer Res Clin Oncol; 2005 Jul; 131(7):479-85. PubMed ID: 15809880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
    Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
    Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.
    Zhou JX; Niehans GA; Shar A; Rubins JB; Frizelle SP; Kratzke RA
    Lung Cancer; 2001 Apr; 32(1):27-38. PubMed ID: 11282426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
    You W; Chen B; Liu X; Xue S; Qin H; Jiang H
    Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
    Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
    Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homeobox Transcription Factor NKX2-1 Promotes
    Harada M; Sakai S; Ohhata T; Kitagawa K; Mikamo M; Nishimoto K; Uchida C; Niida H; Kotake Y; Sugimura H; Suda T; Kitagawa M
    Mol Cancer Res; 2017 Oct; 15(10):1388-1397. PubMed ID: 28634225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.
    Amin KM; Litzky LA; Smythe WR; Mooney AM; Morris JM; Mews DJ; Pass HI; Kari C; Rodeck U; Rauscher FJ
    Am J Pathol; 1995 Feb; 146(2):344-56. PubMed ID: 7856747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.